News | December 08, 2014

Minneapolis Heart Institute Foundation Finds new Care Protocol That Shortens Hospital Stays for Some Heart Surgery Patients

Associated costs also reduced with changed guidelines

cardiovascular surgery, atrial fibrillation, Minneapolis Heart Institute Found.

Image courtesy of Seattle Children's Hospital

December 8, 2014 — Researchers at the Minneapolis Heart Institute Foundation have found that when care teams started following a new set of guidelines for certain patients recovering from cardiovascular surgery, hospital stays (and the associated costs) were reduced.

Thirty to 40 percent of people who undergo major heart surgery (like bypass surgery or heart valve replacement) develop atrial fibrillation (AF) — a dangerously fast and chaotic heartbeat — during their recovery. AF increases the chance of major complications and results in longer hospital stays.

In March 2013, the healthcare team at Minneapolis Heart Institute at Abbott Northwestern Hospital began using a new protocol to optimize and guide medication levels for these patients in real time. The protocol relies on a sophisticated algorithm that considers blood pressure, heart rate and duration of AF to guide decision-making.

A year later, MHIF researchers analyzed electronic medical records of 176 patients who developed AF after bypass or valve replacement surgery to see how and if the new protocol impacted patient care. Of the 176 patients, 55 (31.3 percent) were treated following the AF protocol and 121 (68.7 percent) were not. The researchers found that use of the protocol shortened hospital stays by 71.5 days overall, and associated hospitalization costs by a total of $169,741. The protocol did not significantly impact length of stay in the intensive care unit (ICU) or likelihood of experiencing a post-operative stroke.

Based on these results, researchers feel that achieving 50% protocol use, an estimated 98 hospital days and $232,652 could be saved annually.

For more information: www.mplsheart.org

Related Content

Bilateral Artery Use Does Not Improve 10-Year CABG Outcomes
News | Cardiovascular Surgery | September 06, 2018
While it is firmly established that the use of one internal thoracic artery can improve life expectancy in coronary...
Mandatory Public Coronary Artery Bypass Grafting Reporting Associated With Better Patient Outcomes
News | Cardiovascular Surgery | April 30, 2018
Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery | September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery | September 08, 2017
September 8, 2017 — ClearFlow Inc.
Videos | Cardiovascular Surgery | July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery
News | Cardiovascular Surgery | May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
Risk of Heart Transplant Rejection Reduced by Desensitizing Patient Antibodies
News | Cardiovascular Surgery | May 23, 2017
The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research...
Scientists Show How Cells React to Injury From Open-Heart Surgery
News | Cardiovascular Surgery | May 04, 2017
Cedars-Sinai Heart Institute investigators have learned how cardiac muscle cells react to a certain type of injury that...
ERACS Session Highlights Need for Standardized Best Practices in Cardiac Surgery
News | Cardiovascular Surgery | May 02, 2017
The recently formed group Enhanced Recovery After Cardiac Surgery (ERACS) hosted an organizing session in Boston on...
ClearFlow Receives Frost & Sullivan New Product Innovation Award for PleuraFlow Technology
News | Cardiovascular Surgery | May 01, 2017
ClearFlow Inc. has received the prestigious 2017 Global Frost & Sullivan Award for New Product Innovation. The...
Overlay Init